Literature DB >> 2341925

Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.

N Lurie1, E C Rich, D E Simpson, J Meyer, D L Schiedermayer, J L Goodman, W P McKinney.   

Abstract

OBJECTIVE: To determine the nature, frequency and effects of internal medicine housestaff and faculty contacts with pharmaceutical representatives (PRs). DESIGN AND
SETTING: The authors surveyed internal medicine faculty at seven midwest teaching hospitals and housestaff from two of the teaching programs. The survey asked about type and frequency of contacts with PRs and behavior that might be related to these contacts. T-tests and logistic regression were used to estimate the relationship between reported physician contacts and behavioral changes. PARTICIPANTS: Two hundred forty faculty (78%) and 131 house officers (75%) responded to the survey.
RESULTS: Faculty and housestaff averaged 1.5 brief contacts per month with PRs. Housestaff averaged more than one meal/month at pharmaceutical company expense. Twenty-five percent of faculty and 32% of residents reported changing their practices at least once based on PR contact. Independent predictors of faculty change in practice were brief or extended conversations and free meals. Predictors of faculty requests for formulary addition were brief conversations and receipt of honoraria or research support. Only brief conversations independently predicted housestaff changes in practice.
CONCLUSION: Academic housestaff and faculty have frequent PR contact; such contact is related to changes in behavior. The potential for influence of PRs in academic medical centers should be recognized, and their activities should be evaluated accordingly.

Entities:  

Mesh:

Year:  1990        PMID: 2341925     DOI: 10.1007/bf02600542

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  11 in total

1.  Structural reforms in health-care delivery.

Authors:  Q D Young
Journal:  Arch Intern Med       Date:  1975-07

2.  Sources of drug information used by general practitioners.

Authors:  G Eaton; P Parish
Journal:  J R Coll Gen Pract       Date:  1976

3.  An inquiry into associations between leading physicians and the drug industry in Finland.

Authors:  E Hemminki; T Pesonen
Journal:  Soc Sci Med       Date:  1977-05       Impact factor: 4.634

4.  Source of funding and outcome of clinical trials.

Authors:  R A Davidson
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

5.  Information sources and clinical decisions.

Authors:  J K Stross
Journal:  J Gen Intern Med       Date:  1987 May-Jun       Impact factor: 5.128

6.  Prescribing influences: an overview.

Authors:  D B Worthen
Journal:  Br J Med Educ       Date:  1973-06

7.  Pharmaceutical promotion in Canada: convince them or confuse them.

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1987       Impact factor: 1.663

Review 8.  Communicating drug information to physicians.

Authors:  C M Herman; C A Rodowskas
Journal:  J Med Educ       Date:  1976-03

9.  Continuing education in pulmonary disease for primary-care physicians.

Authors:  J K Stross; R G Hiss; C M Watts; W K Davis; R Macdonald
Journal:  Am Rev Respir Dis       Date:  1983-06

10.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

View more
  26 in total

1.  Pharmaceutical advertising revenue and physician organizations: how much is too much?

Authors:  P A Glassman; J Hunter-Hayes; T Nakamura
Journal:  West J Med       Date:  1999-10

2.  Does participation in clinical trials influence the costs of future management of patients?

Authors:  Anne Hvenegaard; Henrik Hauschildt Juhl; Andreas Habicht
Journal:  Eur J Health Econ       Date:  2011-11-10

3.  Effect of drug sample removal on prescribing in a family practice clinic.

Authors:  Daniel M Hartung; David Evans; Dean G Haxby; Dale F Kraemer; Gabriel Andeen; Lyle J Fagnan
Journal:  Ann Fam Med       Date:  2010 Sep-Oct       Impact factor: 5.166

Review 4.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

5.  The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.

Authors:  Jathin Bandari; Robert M Turner; Bruce L Jacobs; David Canes; Ali Moinzadeh; Benjamin J Davies
Journal:  Urol Pract       Date:  2017-01

6.  Pharmaceutical representatives.

Authors:  L Scarpinato
Journal:  J Gen Intern Med       Date:  1991 Mar-Apr       Impact factor: 5.128

7.  Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.

Authors:  B Hodges
Journal:  CMAJ       Date:  1995-09-01       Impact factor: 8.262

8.  Structured approach to pharmaceutical representatives. Family medicine residency program.

Authors:  S Kelcher; R Brownoff; L M Meadows
Journal:  Can Fam Physician       Date:  1998-05       Impact factor: 3.275

9.  Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes.

Authors:  Adeline Gallini; Blandine Juillard-Condat; Marie-Claude Saux; Florence Taboulet
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

10.  Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians.

Authors:  Peter A Ubel; Christopher Jepson; David A Asch
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.